PMID: 11934652Apr 6, 2002Paper

Effect of 1 year of discontinuation of raloxifene or estrogen therapy on bone mineral density after 5 years of treatment in healthy postmenopausal women

Bone
S J M NeeleJ C Netelenbos

Abstract

The beneficial effects of hormone replacement therapy (HRT), selective estrogen receptor modulators (SERMs), or bisphosphonates in the prevention and treatment of osteoporosis in postmenopausal women have been well established. However, little is known about the effects of discontinuation of treatment on bone mineral density. We investigated the effect of 1 year of discontinuation of the SERM raloxifene (Ral; 60 mg and 150 mg), conjugated equine estrogen (CEE; 0.625 mg), and placebo after 5 years of treatment in a double-blind, randomized study. Thirty-eight of 59 healthy and hysterectomized postmenopausal women (mean age 55 years) completed the treatment and 1 year follow-up period. Lumbar spine and femoral neck bone mineral density (BMD) were performed with dual-energy X-ray absorptiometry, before, during, and at the end of treatment, as well as after 1 year of discontinuation of therapy. One year of discontinuation significantly reduced the mean lumbar spine BMD in the raloxifene- and estrogen-treated women (p < 0.05), whereas mean femoral neck BMD was reduced significantly only in women treated with 60 mg Ral (p < 0.05). The mean percentage change (+/-SD) in lumbar spine BMD was: CEE, -6.2% (+/-3.7%); Ral 60 mg, -2.4% (+/-2...Continue Reading

References

Jun 24, 1978·Lancet·R LindsayJ Garwood
Jul 7, 1979·Lancet·A HorsmanR G Crilly
Jul 1, 1992·Annals of Internal Medicine·E G LufkinB L Riggs
Dec 5, 1991·The American Journal of Medicine·C C Johnston, C W Slemenda
Jun 1, 1987·Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology·K ThomsenP Rødbro
Jan 1, 1995·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·P MaximG M Spitalny
Jun 1, 1997·British Journal of Obstetrics and Gynaecology·P EikenN Kolthoff
Jul 3, 1999·European Journal of Obstetrics, Gynecology, and Reproductive Biology·C Castelo-BrancoJ A Vanrell
Jul 11, 2001·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·F A TrémollieresC Ribot

❮ Previous
Next ❯

Citations

Jan 27, 2005·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·J A KanisB Jönsson
Nov 21, 2008·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·O SheehyJ LeLorier
May 19, 2010·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·J-J BodyJ-Y Reginster
Sep 29, 2011·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·J A KanisC Cooper
Oct 17, 2007·Calcified Tissue International·Edward T MiddletonSheelagh M Doherty
Jul 30, 2009·Wiener medizinische Wochenschrift. Supplement·Hans Peter DimaiUNKNOWN Austrian Society for Bone and Mineral Research (AuSBMR)
Jul 23, 2005·Current Osteoporosis Reports·Oscar Gluck, Michael Maricic
Jun 15, 2011·Nature Reviews. Rheumatology·Aline G CostaJohn P Bilezikian
Mar 19, 2004·The New England Journal of Medicine·Henry G BoneUNKNOWN Alendronate Phase III Osteoporosis Treatment Study Group
Oct 7, 2004·Journal of the American College of Nutrition·Mildred S SeeligBella T Altura
Jun 1, 2006·Menopause : the Journal of the North American Menopause Society·UNKNOWN North American Menopause Society
Jan 26, 2006·Obstetrical & Gynecological Survey·James A SimonAntonio Lombardi
Jan 12, 2010·Menopause : the Journal of the North American Menopause Society
Aug 7, 2012·Clinical Interventions in Aging·Kong Wah Ng
Jun 22, 2011·Therapeutics and Clinical Risk Management·Jonathan D AdachiR Graham G Russell
Jan 14, 2010·Clinical Pharmacokinetics·Teun M PostMeindert Danhof
Mar 29, 2014·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·C Roux, K Briot
Mar 24, 2006·The Consultant Pharmacist : the Journal of the American Society of Consultant Pharmacists·Brigitte L Sicat
Nov 12, 2013·Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry·E Michael LewieckiDavid L Kendler
Nov 30, 2014·Best Practice & Research. Clinical Endocrinology & Metabolism·J Y ReginsterO Bruyere
Oct 26, 2011·Rheumatic Diseases Clinics of North America·Andrew J Laster, S Bobo Tanner
Mar 5, 2016·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·M R McClung
Aug 2, 2005·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Ethel S SirisUNKNOWN Continuing Outcomes Relevant to Evista (CORE) Investigators
Apr 3, 2012·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Steven BoonenFelicia Cosman
Jul 8, 2011·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Jacques P BrownJose Zanchetta
Oct 31, 2012·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Jacques P BrownRachel B Wagman
Nov 26, 2008·Best Practice & Research. Clinical Endocrinology & Metabolism·Socrates E Papapoulos
Sep 16, 2006·Nihon rinsho. Japanese journal of clinical medicine·Masahiro Nozaki
Feb 6, 2014·Current Medical Research and Opinion·Jean-Yves ReginsterPeyman Hadji
Aug 30, 2008·The American Journal of Medicine·Michel Laroche
Jul 3, 2004·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Kristine E EnsrudUNKNOWN Fracture Intervention Trial Long-Term Extension Research Group
May 20, 2006·Current Medical Research and Opinion·Jun IwamotoYoshihiro Sato
Sep 16, 2011·Expert Opinion on Pharmacotherapy·Marie-Paule Lecart, Jean-Yves Reginster
Feb 8, 2011·Expert Opinion on Pharmacotherapy·Seung Sang Ko, V Craig Jordan
Feb 2, 2006·American Journal of Obstetrics and Gynecology·Miriam F Delaney
Oct 30, 2015·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·B Aubry-RozierO Lamy
Apr 5, 2014·Current Opinion in Pharmacology·Kong Wah Ng, T John Martin
May 29, 2016·The Medical Clinics of North America·Kim M O'Connor
Jul 23, 2011·Arquivos brasileiros de endocrinologia e metabologia·André Gonçalves da SilvaMarise Lazaretti-Castro
Oct 27, 2017·Toxicologic Pathology·Jacques P Brown
Jun 3, 2010·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Ginelle A SchmidtKevin G Moores

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The New England Journal of Medicine
Henry G BoneAlendronate Phase III Osteoporosis Treatment Study Group
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA
F A TrémollieresC Ribot
International Journal for Quality in Health Care : Journal of the International Society for Quality in Health Care
Rebecca P Gelber, Todd B Seto
Current Topics in Medicinal Chemistry
W Cameron Black
© 2022 Meta ULC. All rights reserved